or Try an Advanced Search...

    Ophthalmology Stocks List

    Symbol Grade Name % Change
    GKOS A Glaukos Corporation 0.00
    MRK B Merck & Company, Inc. 0.00
    NVS B Novartis AG 0.00
    CRVO B CervoMed Inc. 0.00
    WRBY B Warby Parker Inc. 0.00
    RXST B RxSight, Inc. 0.00
    OCGN B Ocugen, Inc. 0.00
    OCS C Oculis Holding AG 0.00
    REGN C Regeneron Pharmaceuticals, Inc. 0.00
    SGHT C Sight Sciences, Inc 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Facilities Medical Devices Medical Instruments & Supplies Shell Companies
    Related Stock Lists: Medicine Vision Eye Biotechnology Blindness Glaucoma Infectious Diseases Animal Health Antibiotics Biopharmaceutical Clinical Development Contact Lens Diabetes Diabetic Retinopathy Dry Eye Disease Eye Diseases Eye Surgery Eyewear Intraocular Pressure Macular Degeneration

    Related ETFs - A few ETFs which own one or more of the above listed Ophthalmology stocks.

    Symbol Grade Name Weight
    CANC D Tema Oncology ETF 14.3
    FLSW B Franklin FTSE Switzerland ETF 12.58
    EWL B iShares MSCI Switzerland Capped Index Fund 12.34
    PJP A PowerShares Dynamic Pharmaceuticals 11.87
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 11.45
    View all Ophthalmology ETFs...
    Compare ETFs
    Compare CANC to FLSW Compare EWL to FTXH Compare FLSW to EWL

        Ophthalmology Stocks Recent News

        Date Stock Title
        May 31 NVS Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
        May 31 MRK Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study
        May 31 NVS Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia
        May 31 OCGN (OCGN) - Analyzing Ocugen's Short Interest
        May 31 REGN FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
        May 31 NVS Novartis reports positive Phase 3 data for remibrutinib for chronic hives
        May 31 NVS Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety
        May 31 MRK Summit pares gains as ‘China-only’ trial beats Merck’s Keytruda (update)
        May 31 REGN FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
        May 31 OCGN Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
        May 31 MRK Dividend Roundup: Meta Platforms, Merck, Cigna, Halliburton, and more
        May 31 NVS Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
        May 31 WRBY Warby Parker Announces Participation in the TD Cowen 8th Annual Future of the Consumer Conference
        May 31 NVS Novartis reports Phase III data for trials of remibrutinib to treat CSU
        May 31 REGN Regeneron/ Sanofi say FDA has delayed Dupixent COPD label
        May 31 NVS Novartis study points to larger role for targeted leukemia drug
        May 31 REGN Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
        May 31 REGN Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
        May 30 NVS Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
        May 30 OCGN Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Facilities Medical Devices Medical Instruments & Supplies Shell Companies
        Related Stock Lists: Medicine Vision Eye Biotechnology Blindness Glaucoma Infectious Diseases Animal Health Antibiotics Biopharmaceutical Clinical Development Contact Lens Diabetes Diabetic Retinopathy Dry Eye Disease Eye Diseases Eye Surgery Eyewear Intraocular Pressure Macular Degeneration
        Ophthalmology

        Ophthalmology (, or ) is a branch of medicine and surgery (both methods are used) that deals with the diagnosis and treatment of eye disorders. An ophthalmologist is a specialist in Ophthalmology. Their credentials include a doctorate degree in medicine, followed by an additional four years of Ophthalmology residency training. They may or may not receive residency training in internal medicine, pediatrics, or general surgery before the ophthalmology residency. Additional training may be sought through a fellowship in a particular specialty of eye pathology. Ophthalmologists are allowed to use medications to treat eye diseases, implement laser therapy, and perform surgery when needed. Ophthalmologists may participate in academic research on the diagnosis and treatment for eye disorders.

        More about Ophthalmology
        Browse All Tags